SRL
CORT icon

Scientech Research LLC’s Corcept Therapeutics CORT Stock Holding History

Scientech Research LLC’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,915
Closed -$484K – 525
2025
Q4 		$484K Buy
+13,915
New +$1.09M 0.3% 94
2025
Q2 		– Sell
-14,181
Closed -$1.62M – 635
2025
Q1 		$1.62M Sell
14,181
-4,716
-25% -$287K 0.43% 25
2024
Q4 		$952K Buy
+18,897
New +$990K 0.27% 114

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Scientech Research LLC's CORT Position: Q1 2026 in Review

Scientech Research LLC sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 13,915 shares — an estimated $484K sold.

Scientech Research LLC first reported a position in CORT in Q4 2024 and held it in 3 quarters. The position peaked at $1.62M in Q1 2025. 352 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Scientech Research LLC reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Scientech Research LLC sold 13,915 Corcept Therapeutics shares in Q1 2026, an estimated $484K.
  • Scientech Research LLC first reported a position in Corcept Therapeutics in Q4 2024 and held it in 3 quarters.
  • Scientech Research LLC's Corcept Therapeutics position peaked at $1.62M in Q1 2025.
  • 352 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.